• 2026.11.09
  • Investor Relations

  Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2027 [IFRS]

• 2026.11.09
  • Investor Relations

  Financial Results for Q2 - FY2026

• 2026.11.02
  • Investor Relations

  Notice Regarding Acquisition of Shares of GOO Chemical Co., Ltd. (to Make It a Subsidiary)

• 2026.10.29
  • Investor Relations

  Notice Regarding Purchase of Treasury Shares

• 2026.10.26
  • Research and Development

  Nippon Shokubai to Exhibit at TIDES Europe 2026

• 2026.09.29
  • Research and Development

  Nippon Shokubai Enters into Strategic Collaboration with PURMX Therapeutics on Drug Delivery System (DDS) Material “Fol-Dab8” -Evaluating the Potential of Combining Fol-Dab8 with Naturally Occurring microRNA for Novel Oligonucleotide Therapeutics-

자세히 보기

• 2026.11.09
  • Investor Relations

  Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2027 [IFRS]

• 2026.11.09
  • Investor Relations

  Financial Results for Q2 - FY2026

• 2026.11.02
  • Investor Relations

  Notice Regarding Acquisition of Shares of GOO Chemical Co., Ltd. (to Make It a Subsidiary)

• 2026.10.29
  • Investor Relations

  Notice Regarding Purchase of Treasury Shares

• 2026.08.27
  • Investor Relations

  Notice Concerning Partial Changes to the Construction Plan of a New Plant for LiFSI (IONEL), an Electrolyte for Lithium-ion Batteries

• 2026.08.07
  • Investor Relations

  Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [IFRS]

자세히 보기

• 2025.12.15
  • Sustainability

  Nippon Shokubai Published the Integrated Report “TechnoAmenity Report 2025,” and “Financial Report 2025.”

• 2025.10.03
  • Sustainability

  “Nippon Shokubai – Yugawara Myriad Leaves Forest” Certified as a “Nature Symbiosis Site” by the Ministry of the Environment -Recognized for Efforts in Biodiversity Conservation and Restoration-

• 2025.09.26
  • Sustainability

  Nippon Shokubai Releases Revised TCFD Report

• 2025.06.26
  • Sustainability

  Nippon Shokubai’s U.S. Group Company Acquires ISCC PLUS Certification for Acrylic Acid and Superabsorbent Polymers -Contributing to Reduction of Environmental Impact in Applications Such as Paints and Disposable Diapers through Nippon Shokubai’s Global Supply System-

• 2024.11.29
  • Sustainability
  • Investor Relations

  Nippon Shokubai Published “TechnoAmenity Report 2024,” and “Financial Report 2024.”

• 2024.05.29
  • Sustainability
  • Investor Relations

  Nippon Shokubai Begins Manufacturing and Marketing Halal-certified and Biomass-derived Acrylic Acid, Acrylates, and Superabsorbent Polymers in Indonesia　-Contributing to Reducing the Environmental Impact of Paints, Diapers, etc. throughout the Product Supply Chain-

자세히 보기

• 2026.10.26
  • Research and Development

  Nippon Shokubai to Exhibit at TIDES Europe 2026

• 2026.09.29
  • Research and Development

  Nippon Shokubai Enters into Strategic Collaboration with PURMX Therapeutics on Drug Delivery System (DDS) Material “Fol-Dab8” -Evaluating the Potential of Combining Fol-Dab8 with Naturally Occurring microRNA for Novel Oligonucleotide Therapeutics-

• 2025.10.30
  • Research and Development

  Nippon Shokubai and MHI to Develop Ammonia Cracking System for NEDO’s “Development of Technologies for Building a Competitive Hydrogen Supply Chain” Project

• 2025.09.11
  • Research and Development

  NEDO Selects Project for Developing Mass Production Technologies of Game-Changing Latent Heat Storage Microcapsules (h-MEPCM) -Joint Research by Nippon Shokubai, Hokkaido University, and Toyo Aluminium Speeds Up the Practical Implementation of Thermal Energy Storage Technology-

• 2025.08.07
  • Research and Development

  Launch of Nippon Shokubai Group Open Innovation Center -Accelerating Innovation through Collaboration with Nippon Nyukazai and Nippoh Chemicals-

• 2025.06.24
  • Research and Development

  Nippon Shokubai Plans to Expand Its GMP-Compliant Nucleic Acid Drug API Manufacturing Capacity Tenfold

자세히 보기